Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells

por Liu, Mingyue, Dong, Qi, Chen, Bo, Liu, Kaidong, Zhao, Zhangxiang, Wang, Yuquan, Zhuang, Shuping, Han, Huiming, Shi, Xingyang, Jin, Zixin, Hui, Yang, Gu, Yunyan
Publicado 2023

Discovering a qualitative transcriptional signature of homologous recombination defectiveness for prostate cancer

por Li, Yawei, Zhao, Zhangxiang, Ai, Liqiang, Wang, Yuquan, Liu, Kaidong, Chen, Bo, Chen, Tingting, Zhuang, Shuping, Xu, Huanhuan, Zou, Min, Gu, Yunyan, Li, Xia
Publicado 2021

A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level

por Zhuang, Shuping, Chen, Tingting, Li, Yawei, Wang, Yuquan, Ai, Liqiang, Geng, Yiding, Zou, Min, Liu, Kaidong, Xu, Huanhuan, Wang, Linzhu, Zhao, Zhangxiang, Chang, Zhiqiang, Gu, Yunyan
Publicado 2021

Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome

por Dong, Qi, Liu, Mingyue, Chen, Bo, Zhao, Zhangxiang, Chen, Tingting, Wang, Chengyu, Zhuang, Shuping, Li, Yawei, Wang, Yuquan, Ai, Liqiang, Liu, Yaoyao, Liang, Haihai, Qi, Lishuang, Gu, Yunyan
Publicado 2021

A genetic map of the chromatin regulators to drug response in cancer cells

por Chen, Bo, Li, Pengfei, Liu, Mingyue, Liu, Kaidong, Zou, Min, Geng, Yiding, Zhuang, Shuping, Xu, Huanhuan, Wang, Linzhu, Chen, Tingting, Li, Yawei, Zhao, Zhangxiang, Qi, Lishuang, Gu, Yunyan
Publicado 2022